BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 29754996)

  • 1. DCE-MRI in Human Gliomas: A Surrogate for Assessment of Invasive Hypoxia Marker HIF-1Α Based on MRI-Neuronavigation Stereotactic Biopsies.
    Xie Q; Wu J; Du Z; Di N; Yan R; Pang H; Jin T; Zhang H; Wu Y; Zhang Y; Yao Z; Feng X
    Acad Radiol; 2019 Feb; 26(2):179-187. PubMed ID: 29754996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can dynamic contrast-enhanced MRI evaluate VEGF expression in brain glioma? An MRI-guided stereotactic biopsy study.
    Di N; Cheng W; Jiang X; Liu X; Zhou J; Xie Q; Chu Z; Chen H; Wang B
    J Neuroradiol; 2019 May; 46(3):186-192. PubMed ID: 29752976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic contrast-enhanced perfusion parameters in ovarian cancer: Good accuracy in identifying high HIF-1α expression.
    Lindgren A; Anttila M; Rautiainen S; Arponen O; Hämäläinen K; Könönen M; Vanninen R; Sallinen H
    PLoS One; 2019; 14(8):e0221340. PubMed ID: 31437208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Textural features of dynamic contrast-enhanced MRI derived model-free and model-based parameter maps in glioma grading.
    Xie T; Chen X; Fang J; Kang H; Xue W; Tong H; Cao P; Wang S; Yang Y; Zhang W
    J Magn Reson Imaging; 2018 Apr; 47(4):1099-1111. PubMed ID: 28845594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravoxel Incoherent Motion Combined With Dynamic Contrast-Enhanced Perfusion MRI of Early Cervical Carcinoma: Correlations Between Multimodal Parameters and HIF-1α Expression.
    Li X; Wu S; Li D; Yu T; Zhu H; Song Y; Meng L; Fan H; Xie L
    J Magn Reson Imaging; 2019 Sep; 50(3):918-929. PubMed ID: 30648775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioma grade discrimination with dynamic contrast-enhanced MRI: An accurate analysis based on MRI guided stereotactic biopsy.
    Wu J; Liang Z; Deng X; Xi Y; Feng X; Yao Z; Shu Z; Xie Q
    Magn Reson Imaging; 2023 Jun; 99():91-97. PubMed ID: 36803634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic contrast-enhanced MRI of nasopharyngeal carcinoma: correlation of quantitative dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parameters with hypoxia-inducible factor 1α expression and tumor grade/stage.
    Liu L; Hu L; Zeng Q; Peng D; Chen Z; Huang C; Liu Z; Wen Q; Zou F; Yan L
    Ann Palliat Med; 2021 Feb; 10(2):2238-2253. PubMed ID: 33725777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic Contrast-Enhanced Perfusion MRI and Diffusion-Weighted Imaging in Grading of Gliomas.
    Arevalo-Perez J; Peck KK; Young RJ; Holodny AI; Karimi S; Lyo JK
    J Neuroimaging; 2015; 25(5):792-8. PubMed ID: 25867683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminant analysis to classify glioma grading using dynamic contrast-enhanced MRI and immunohistochemical markers.
    Awasthi R; Rathore RK; Soni P; Sahoo P; Awasthi A; Husain N; Behari S; Singh RK; Pandey CM; Gupta RK
    Neuroradiology; 2012 Mar; 54(3):205-13. PubMed ID: 21541688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of quantitative parameters of magnetic resonance perfusion-weighted imaging with vascular endothelial growth factor, microvessel density and hypoxia-inducible factor-1α in nasopharyngeal carcinoma: Evaluation on radiosensitivity study.
    Hu Y; E H; Yu X; Li F; Zeng L; Lu Q; Xi X; Shen L
    Clin Otolaryngol; 2018 Apr; 43(2):425-433. PubMed ID: 28892580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfusion imaging of brain gliomas using arterial spin labeling: correlation with histopathological vascular density in MRI-guided biopsies.
    Ningning D; Haopeng P; Xuefei D; Wenna C; Yan R; Jingsong W; Chengjun Y; Zhenwei Y; Xiaoyuan F
    Neuroradiology; 2017 Jan; 59(1):51-59. PubMed ID: 27924360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amide proton transfer-weighted magnetic resonance image-guided stereotactic biopsy in patients with newly diagnosed gliomas.
    Jiang S; Eberhart CG; Zhang Y; Heo HY; Wen Z; Blair L; Qin H; Lim M; Quinones-Hinojosa A; Weingart JD; Barker PB; Pomper MG; Laterra J; van Zijl PCM; Blakeley JO; Zhou J
    Eur J Cancer; 2017 Sep; 83():9-18. PubMed ID: 28704644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between ¹⁸F-fluoromisonidazole PET and expression of HIF-1α and VEGF in newly diagnosed and recurrent malignant gliomas.
    Kawai N; Lin W; Cao WD; Ogawa D; Miyake K; Haba R; Maeda Y; Yamamoto Y; Nishiyama Y; Tamiya T
    Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1870-8. PubMed ID: 24781871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
    Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
    Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging.
    Li X; Zhu Y; Kang H; Zhang Y; Liang H; Wang S; Zhang W
    Cancer Imaging; 2015 Mar; 15(1):4. PubMed ID: 25889239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soft tissue sarcoma: correlation of dynamic contrast-enhanced magnetic resonance imaging features with HIF-1α expression and patient outcomes.
    Li X; Xie Y; Hu Y; Lu R; Li Q; Xiong B; Tao H; Chen S
    Quant Imaging Med Surg; 2022 Oct; 12(10):4823-4836. PubMed ID: 36185052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioma: Application of histogram analysis of pharmacokinetic parameters from T1-weighted dynamic contrast-enhanced MR imaging to tumor grading.
    Jung SC; Yeom JA; Kim JH; Ryoo I; Kim SC; Shin H; Lee AL; Yun TJ; Park CK; Sohn CH; Park SH; Choi SH
    AJNR Am J Neuroradiol; 2014 Jun; 35(6):1103-10. PubMed ID: 24384119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Tumor Hypoxia in C6 Glioma Rat Model With Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
    Hou W; Xue Y; Tang W; Pan H; Xu M; Li X; Bi S; Shen Y; Qian Y; Yu Y
    Acad Radiol; 2019 Aug; 26(8):e224-e232. PubMed ID: 30385206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of artery input function on dynamic contrast-enhanced MRI for determining grades of gliomas.
    Jia L; Wu X; Wan Q; Wan L; Jia W; Zhang N
    Br J Radiol; 2021 Mar; 94(1119):20200699. PubMed ID: 33332981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients.
    Ulyte A; Katsaros VK; Liouta E; Stranjalis G; Boskos C; Papanikolaou N; Usinskiene J; Bisdas S
    Neuroradiology; 2016 Dec; 58(12):1197-1208. PubMed ID: 27796446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.